Caymax Lars Kinesitherapie

Active

Private limited companyfounded 2025active for 1 yearDonk 55, 2360 Oud-Turnhout, BelgiumKBO/BCE: BE 1020.775.243

Summary

Caymax Lars Kinesitherapie has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €25,666 and a net result of €22,666. Its solvency ranks better than 36% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Caymax Lars KinesitherapieActiveChecked score 95/100

Risk analysis Report Compare

Activity

Physiotherapy

NACE 86951

1 site

Size

≈ €110,000turnover 2025, estimated

Equity: €25,666
Profit: €22,666

Turnover estimated from the gross margin

Financial health

95 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

CAYMAX,LarsDirector

2025 accounts 38 days early

Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.06, cash €32,340Figures for financial year 2025 (filed 23-06-2026)Size: total assets €56,645Show the evidence

Checked score

Score 2025

95 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 57% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength

Strong

Solvency 70

equity 45.3% of total assets

Liquidity 72

short-term debt 54.7% · cash 57.1%

Profitability 100

return on assets 40.0%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)

Last 24 months 04-2026: 0.3% 05-2026: 0.3%● unchanged vs 04-2026highest value 06-2026: 0.3%● unchanged vs 05-2026highest value 07-2026: < 0.1%▼ -0.3 percentage points vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €2,000 on 30-day terms is acceptable

Liquidity tight (current ratio 1.06, below the usual 1.5; short-term debt: 54.7% and cash: 57.1% of total assets), and 54.7% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 36% on solvency, 53% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 1.06, cash €32,340

NBB · annual accounts

Figures for financial year 2025 (filed 23-06-2026)

NBB · annual accounts

Size: total assets €56,645

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Young company

Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.

KBO · incorporation date

Age against the risk zone

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.

NBB · 1 filing

Deviation from the deadline

2025

38 days early

← before the deadline after the deadline →

Searched, nothing found (1)

No strike-offs in the KBO publications

Searched since incorporation in 2025.

KBO publications · our coverage

23-06-2026 Annual accounts filedfinancial year 2025 · micro…
11-03-2025 IncorporationAppointment: CAYMAX,Lars (director) · Permanent…

Key points

One director decidessole director in office 1 View
Total assets 2025first financial year filed €56,645 View
Active since 2025founded 07-03-2025 1 years View

By topic

Financials

Financial year: 2025
Total assets: €56,645
Profit: €22,666
Solvency: 45.3%

Go to Financials

Board & ownership

Board: 1 member

CAYMAX,LarsDirector

Go to Board & ownership

Timeline

Events: 2
Since: 2025

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: PhysiotherapyNACE 86951
Founded: 07-03-2025
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 10

Annual meeting: Third Friday of June at 09:00

Go to Articles of association

Key facts about Caymax Lars Kinesitherapie

What is the company number of Caymax Lars Kinesitherapie?: 1020.775.243. In Belgium the VAT number is the company number with BE in front: BE 1020.775.243.
Where is Caymax Lars Kinesitherapie based?: The registered office is at Donk 55, 2360 Oud-Turnhout.Company details
What does Caymax Lars Kinesitherapie do?: According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of Caymax Lars Kinesitherapie?: Private limited company (BV).
When was Caymax Lars Kinesitherapie founded?: On 07-03-2025.
Is Caymax Lars Kinesitherapie still active?: Yes, Caymax Lars Kinesitherapie is an active enterprise in the KBO register.
What is the turnover of Caymax Lars Kinesitherapie?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Caymax Lars Kinesitherapie profitable?: In financial year 2025, Caymax Lars Kinesitherapie made a profit of €22,666.
Where can I find the annual accounts of Caymax Lars Kinesitherapie?: Caymax Lars Kinesitherapie filed 1 annual account with the National Bank of Belgium, for financial year 2025.